A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Phase 3CompletedNCT00092040

Organon and Co936 enrolled

Overview

The purpose of this study and 12 month extension is to evaluate the effects of two investigational drugs on osteoporosis in postmenopausal women.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

936

Sex: FEMALEMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Postmenopausal women with osteoporosis Exclusion Criteria: * Any known allergy to the study drug

Mean percent change from baseline in hip trochanter bone mineral density (BMD)

Mean percent change from baseline in PA lumbar spine, total hip, and femoral neck BMD

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.